DocStoX is a free AI-powered research platform for Indian equity markets, covering 5,700+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (5,700+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 76 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

Neutral impactCompany

CORONA Remedies Limited — Analyst/Investor Meet Para A-XBRL

NSE 1 hr ago·18 Sept 2026, 9:35 am

Corona Remedies

Corona Remedies Limited has informed stock exchanges about its upcoming meeting with analysts and institutional investors. This announcement signals the company's intent to engage directly with the investment community to discuss its business performance and future outlook.

For investors, such meetings provide a valuable opportunity to gain clarity on the company's strategic direction and operational health. It allows the management to address market queries and share insights that are not always available in public filings.

Investors should watch for key takeaways regarding the company's growth plans and any updates on its product pipeline. Monitoring the company's subsequent share price reaction can also offer clues about how the market interprets the information shared during the interaction.